'For
the quarter ending Sept 2023, consolidated Net sales (including other operating income) of Shalby has increased 17.93% to Rs 237.98 crore compared to quarter ended Sept 2022. Sales of Health care services segment has gone up 25.62% to Rs 223.34 crore (accounting for 93.84% of total sales). Sales of Manufacturing of implants segment has gone down 38.98% to Rs 14.65 crore (accounting for 6.16% of total sales). Profit before interest, tax and other unallocable items (PBIT) has jumped 48.60% to Rs 42.63 crore. PBIT of Health care services segment rose 42.30% to Rs 47.62 crore (accounting for 111.71% of total PBIT). PBIT of Manufacturing of implants segment fell 4.48% to Rs -4.99 crore (accounting for -11.71% of total PBIT).
PBIT margin of Health care services segment rose from 18.82% to 21.32%. PBIT margin of Manufacturing of implants segment fell from negative 19.90% to negative 34.07%....
Pleaselogin & subscribe to view the full report.
More Reports
-
(30-Aug-2024)
Gillette India
-
Net down 5% on lower sales
-
Net jump 159% on good operating show
-
Net up 50% on good operating show
|